Shah Rutul Rinsider trades
In SEC Form 4 filings, Shah Rutul R is listed as Chief Operating Officer of Precigen, Inc. (PGEN). In the last 90 days, Shah Rutul R sold $375K of Precigen, Inc. (PGEN) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PGENPrecigen, Inc. | Chief Operating Officer | 9 | Aug 25 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-25
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PGENPrecigen, Inc. | Aug 25 | Aug 25 | M | 15,342 | $2.33 | $35,747 | 484,207 | Yes | Form 4 |
| PGENPrecigen, Inc. | Aug 25 | Aug 25 | S | 15,342 | $7.50 | Sale −$115,065 | 468,865 | Yes | Form 4 |
| PGENPrecigen, Inc. | Aug 25 | Aug 25 | M · derivative | 15,342 | $2.33 | $35,747 | 73,304 | Yes | Form 4 |
| PGENPrecigen, Inc. | Aug 23 | Aug 25 | M | 7,500 | not reported | not reported | 472,512 | Yes | Form 4 |
| PGENPrecigen, Inc. | Aug 23 | Aug 25 | F | 3,647 | $7.20 | $26,258 | 468,865 | Yes | Form 4 |
| PGENPrecigen, Inc. | Aug 23 | Aug 25 | M · derivative | 7,500 | $0.00 | $0 | 57,292 | Yes | Form 4 |
| PGENPrecigen, Inc. | Aug 21 | Aug 25 | M | 34,658 | $2.33 | $80,753 | 499,670 | Yes | Form 4 |
| PGENPrecigen, Inc. | Aug 21 | Aug 25 | S | 34,658 | $7.50 | Sale −$259,935 | 465,012 | Yes | Form 4 |
| PGENPrecigen, Inc. | Aug 21 | Aug 25 | M · derivative | 34,658 | $2.33 | $80,753 | 88,646 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.